Meloxicam
High-purity pharmaceutical grade Meloxicam manufactured to meet stringent USP/EP specifications for pharmaceutical formulations and research applications. Our pharmaceutical grade material delivers exceptional purity and consistency for critical pharmaceutical manufacturing.
- USP/EP Grade Specifications
- High Purity (≥99.0%)
- Comprehensive Analytical Testing
- Regulatory Compliance Documentation
- Pharmaceutical Manufacturing Grade
- Quality Assurance Certified
Technical Specifications
Applications
Industry-Specific Grades
DRAVYOM offers specialized Meloxicam grades tailored for specific NSAID pharmaceutical requirements, ensuring optimal performance and regulatory compliance across diverse anti-inflammatory drug manufacturing applications.
USP Grade (United States Pharmacopeia)
EP Grade (European Pharmacopoeia)
Anti-inflammatory Research Grade
Reference Standard Grade
Quality Standards
DRAVYOM's Meloxicam API is manufactured under stringent quality control protocols, meeting international pharmaceutical standards including USP, EP, and cGMP specifications. Our pharmaceutical-grade production ensures consistent performance and regulatory compliance.
Advanced Chemical Properties & Performance
Meloxicam exhibits exceptional pharmaceutical properties essential for anti-inflammatory applications. Its ultra-pure composition and precise molecular structure ensure reliable performance in demanding pharmaceutical formulations and arthritis treatment therapies.
Pharmaceutical Properties
Physical Properties
Formulation Performance
Purity Specifications
Stability Properties
Performance Characteristics
Detailed performance metrics demonstrate Meloxicam superiority in pharmaceutical applications with exceptional efficacy, bioavailability, and reproducibility across diverse formulation types and therapeutic protocols.
Therapeutic Performance
Bioavailability: ≥89% oral absorption
Excellent anti-inflammatory efficacyDissolution Rate
Release: ≥75% in 45 minutes
Consistent drug release profileAnalytical Performance
Purity: ≥99.0% HPLC
Superior analytical precisionStability Performance
Shelf life: 5 years under proper storage
Extended pharmaceutical integrityBatch Reproducibility
Variation: ±1.0% between batches
Exceptional lot-to-lot consistencyProcessing Performance
Compressibility: Good with proper excipients
Superior manufacturing efficiencySafety Information
Pharmaceutical grade material requiring appropriate handling procedures. Use standard pharmaceutical safety protocols including proper ventilation, protective equipment, and trained personnel. Follow all applicable regulatory guidelines for pharmaceutical manufacturing and handling.
Storage & Handling
Store in original pharmaceutical packaging in a controlled environment. Maintain temperature and humidity conditions as specified. Protect from light and moisture. Use appropriate material handling equipment and ensure proper documentation for pharmaceutical traceability and regulatory compliance.
Chemical Mechanisms & Reaction Pathways
Meloxicam exhibits selective anti-inflammatory activity through preferential cyclooxygenase-2 inhibition and unique pharmacological pathways, enabling precise anti-inflammatory applications with reduced gastrointestinal side effects.
Selective COX-2 Inhibition
Preferential inhibition of cyclooxygenase-2 over cyclooxygenase-1
Reduces inflammation while minimizing GI toxicityProstaglandin Modulation
Selective reduction of inflammatory prostaglandins
Maintains protective prostaglandin functionsProtein Binding
High protein binding (99.4%) for sustained action
Extended half-life and improved efficacyHepatic Metabolism
CYP2C9 mediated metabolism with predictable kinetics
Consistent pharmacokinetic profileRegulatory Compliance & Documentation
Comprehensive regulatory compliance ensures global pharmaceutical access with complete documentation packages supporting international standards and drug development validations.
USP Specifications
United States Pharmacopeia pharmaceutical grade standards compliance
EP Standards
European Pharmacopoeia specifications for pharmaceutical manufacturing
cGMP Manufacturing
Current Good Manufacturing Practice certified production facility
ICH Guidelines
International Conference on Harmonisation quality standards
DMF Support
Drug Master File documentation for regulatory submissions
Quality Documentation
Complete analytical documentation package with stability data
Technical Support & Value-Added Services
DRAVYOM's pharmaceutical development team provides comprehensive formulation support, analytical method development, and regulatory guidance to optimize Meloxicam performance in your specific pharmaceutical applications.
Formulation Development
- Dosage form optimization support
- Solubility enhancement strategies
- Bioavailability improvement guidance
- Extended release formulation design
Analytical Services
- Certificate of Analysis verification
- Custom impurity profiling
- Method validation support
- Stability testing programs
Technical Support
- Pharmaceutical troubleshooting consultation
- cGMP compliance guidance
- Process optimization support
- Quality system implementation
Supply Solutions
- Consistent batch scheduling
- Emergency supply arrangements
- Custom packaging options
- Global pharmaceutical distribution
Environmental Impact & Sustainability
Our Meloxicam production emphasizes environmental responsibility through sustainable pharmaceutical manufacturing practices, waste minimization, and comprehensive environmental impact management for pharmaceutical operations.
Waste Minimization
Optimized synthesis with minimal pharmaceutical waste generation
Water Treatment
Advanced pharmaceutical wastewater treatment and recycling systems
Green Chemistry
Environmentally conscious synthesis with emission controls
Safe Disposal
Comprehensive guidance for pharmaceutical waste management
ISO 14001
Environmental management system certified pharmaceutical production
Carbon Footprint
Reduced carbon footprint through process optimization
Manufacturing Excellence & Quality Control
DRAVYOM's state-of-the-art pharmaceutical manufacturing facility employs advanced synthesis technology and continuous monitoring systems to ensure consistent Meloxicam quality and performance across all production batches.
Production Process
Advanced synthesis and purification in controlled cGMP environment
Multi-stage crystallization for pharmaceutical grade qualityQuality Testing
Comprehensive analytical testing protocol including related substances analysis
HPLC verification and spectroscopic analysisQuality Systems
ISO 9001:2015 quality management with pharmaceutical manufacturing accreditation
Continuous improvement and process validationPackaging Control
Pharmaceutical-grade containers with controlled atmosphere packaging
Light protection and moisture controlMarket Applications & Performance Data
Comprehensive pharmaceutical development data demonstrating Meloxicam effectiveness across diverse therapeutic applications with quantified performance metrics and clinical development validations.
Pharmaceutical Manufacturing
Clinical Development
Manufacturing Scale
DRAVYOM Competitive Advantages
Superior Purity
Consistently exceeds USP/EP specifications with ultra-low impurities and exceptional pharmaceutical performance
Reliable Supply
Guaranteed availability with strategic inventory management and pharmaceutical-grade production scheduling
Pharmaceutical Expertise
Dedicated pharmaceutical development team provides formulation and regulatory support
Quality Assurance
Comprehensive certificates with complete analytical data and regulatory documentation
Global Standards
International compliance with USP, EP, and ICH specifications for worldwide pharmaceutical acceptance
Partnership Approach
Collaborative relationships with pharmaceutical companies and custom API development services